Ifp Advisors, Inc Akari Therapeutics PLC Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.59 - $1.87 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.69 - $2.85 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.81 - $3.88 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.5 - $2.02 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$1.58 - $2.37 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.16 - $2.61 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$1.06 - $2.16 $0 - $0	0 New	0 $0
Q2 2018 Aug 07, 2018	SELL	$1.77 - $2.28 $1,770 - $2,280	-1,000 Closed	0 $0
Q1 2018 Jun 03, 2019	BUY	$1.77 - $4.39 $1,770 - $4,390	1,000 New	1,000 $4,000
Q1 2018 May 09, 2018	SELL	$1.77 - $4.39 $1,770 - $4,390	-1,000 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$4.08 - $7.4 $4,080 - $7,400	1,000	1,000 $0

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $59.3M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.